Our results support previous findings as they also showed significantly higher percentages and absolute numbers of CD4+/CTLA-4+ and CD8+/CTLA-4+ T lymphocytes in patients with CLL than in the control group. The gene discussed is CTLA4; the disease is B-cell chronic lymphocytic leukemia.